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3D - tridimensional 
ACN - acetonitrile 
AD - Alzheimer’s disease  
ATP - adenosine triphosphate 
CHD - coronary heart disease 
CuZn-SOD - copper & zinc-containing superoxide dismutation 
DNA - deoxyribonucleic acid  
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H2O2 - hydrogen peroxide 
HO2
·- - hydroperoxyl radical 
HPLC - high performance liquid chromatography 
LC-MS - liquid chromatography – mass spectrometry 
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NO· - nitric oxide 
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· - nitrogen dioxide  
NOS - nitric oxide synthase  
1O2 - singlet oxygen  
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OH· - hydroxyl radical 
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1.1 Mitochondrial production of reactive species  
 
Mitochondria are renowned for being a major production site of reactive oxygen 
species (ROS). Free radicals of oxygen (superoxide anion, O2
·-; hydroxyl, OH·) as well as 
species that do not have an unpaired electron (hydrogen peroxide, H2O2) belong to the group 
of ROS. The main ROS produced within mitochondria is O2
·- and its formation occurs as a 
consequence of one-electron reduction of O2 in electron transport chain (ETC) (Fig.1) 
(Turrens J. F., 2003). It has been frequently stated in literature that as much as 2 % of O2, 
consumed by mitochondria, fails to be converted to water and that is, consequently, reduced 
by single electron giving O2
·- (Boveris A and Chance B., 1973). However, it appears that in 
reality much less of O2 diverts from the full reduction in ETC and this amount is 
approximately 0.2 % of mitochondrial O2 (St-Pierre J. et al., 2002; Brand M. D., 2010). 
Approximately 1 % of O2
·- is protonated to hydroperoxyl radical (HO2
·-), which is a 
conjugated acid of O2
·-. HO2
·- is a very reactive radical species (De Grey A. D., 2002; Jezek P 
and Hlavata L., 2005). A substantial amount of O2
·- is generated by Complex I (NADH-
ubiquinone oxidoreductase), where the radical is released exclusively into mitochondrial 
matrix. It is believed that iron-sulphur centres (Fe-S), ubiquinone (UQ) and flavin 
mononucleotide (FMN) cofactor take part in production of radicals that can partially reduce 
molecular oxygen into O2
·-. Fully reduced FMN is found to participate in these events mainly 
during forward electron transport, while the dominant site for ROS production in reverse 
electron transfer (RET), in which electrons flow from reduced ubiquinone – ubiquinol 
(UQH2) back to NAD
+, is UQ-binding site. This is particularly encouraged by high membrane 
potential, which allows this reaction to happen from thermodynamic point of view (Chen Y. 
R. et al., 2005; Grivennikova V. G and Vinogradov A. D., 2006; Kussmaul L and Hirst J., 
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2006; Judge S and Leeuwenburgh C., 2007; Kowaltowski A. J. et al., 2009). If we consider 
O2
·- production by RET as a mere result of single-electron reduction of O2 by Complex I 
components, then in that case we can say that Complex II (succinate dehydrogenase) does not 
generate this radical in a relevant quantity (Liu Y. et al., 2002; Grivennikova V. G and 
Vinogradov A. D., 2006). Another significant source of free radicals within ETC is Complex 
III (ubiquinone-cytochrome c oxidoreductase) where semiubiquinone radical (UQ·-) is formed 
during electron transport through this complex. It is generally accepted that UQ·- may be 
produced on both sides of the inner mitochondrial membrane (St-Pierre J. et al., 2002; 
Quinlan C. L. et al., 2011). As for Complex IV (cytochrome c oxidase), it is well-known that 
four-electron reduction of O2 to H2O occurs in a stepwise fashion thus producing radical 
intermediates. However, it does not deliver them to its surroundings in a measurable amount 
(Miwa S. et al., 2003). Apart from the complexes of ETC, other mitochondrial enzymes that 
participate in donating electrons to ETC are also capable of producing ROS. Such enzymes 
are glycerol 3-phosphate dehydrogenase and electron transferring flavoprotein-ubiquinone 
oxidoreductase (St-Pierre J. et al., 2002). Mitochondrial glycerol 3-phosphate dehydrogenase 
is also a part of electron transport in the inner mmbrane and it is a source of superoxide at 
least in brown adipose tissue (Drahota Z. et al., 2002). Furthermore, enzymes of citric acid 
cycle pyruvate dehydrogenase and α-ketoglutarate dehydrogenase are also recognized as 
sources of mitochondrial ROS, where dihydrolipoyl dehydrogenase subunit of the enzyme is 
responsible for ROS production (Gazaryan I. G. et al., 2002; Starkov A. A. et al., 2004; 
Tretter L and Adam-Vizi V., 2004). Monoamine oxidase, an outer mitochondrial membrane 
enzyme that catalyses oxidative deamination of monoamines (Cadenas E and Davies K. J., 
2000) and dihydroorotate dehydrogenase, located in the inner mitochondrial membrane and a 
component of pyrimidine de novo synthesis (Lenaz G., 2001), are able to produce ROS as 
well. As far as the fate of mitochondrial O2
·- is concerned, it usually becomes a subject of 
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dismutatation with a subsequent production of H2O2. This may be followed, if transition 
metals are present, by further reduction of H2O2 to a potent oxidant hydroxyl radical (OH
·). 
H2O2 reacts with O2
·- in Haber-Weiss reaction to produce OH· along with hydroxide anion and 
molecular oxygen. The first step of this reaction is, however, reduction of ferric ions to 
ferrous (Fe3+ + O2
·- → Fe2+ + O2). Ferrous ions are further re-oxidized in the second step, 
which is named Fenton reaction (Fe2+ + H2O2 → Fe
3+ + OH- + OH·).   Dismutation of O2
·- 
may occur spontaneously or it can be catalysed by the action of a specific enzyme - 
superoxide dismutase (SOD), which occurs in mitochondria in two forms, a manganese 
containing matrix isoenzyme (Mn-SOD) and a copper-zinc containing isoenzyme from 
intermembrane space (CuZn-SOD) (Buettner G. R. et al , 2006).  
It has been reported that singlet oxygen (1O2) is also generated in vivo, for example 
during decomposition of lipid hydroperoxides. These particularly unstable early products of 
lipid peroxidation easily decompose in the presence of metal ions to peroxyl or alkoxyl 
radicals, which in turn in a so-called self-reaction give rise to 1O2. Whether 
1O2 can be 
generated in this manner directly by mitochondria is debatable and the stronger evidence is 
still needed to confirm that. Nonetheless, this cannot be excluded since lipid peroxidation, 
which normally takes place in PUFA enriched mitochondria, is regarded as a source of 1O2 
(Miyamoto S. et al., 2003). 
Another group of reactive species that is as important in biology as ROS is called 
reactive nitrogen species (RNS). The most prominent member of this group is nitric oxide 
(NO·), which is a free radical itself. NO· arises in the reaction between arginine and O2 that is 
catalysed by nitric oxide synthase (NOS). There are thr e isoforms of NOS: neuronal, 
inducible and endothelial. It is presumed that NOS are localized in every cell compartment 
(Castro L. et al., 2011; Del Rio L. A., 2011; Robinso  M. A. et al., 2011; Forstermann U and 
Sessa W. C., 2012). Considering that NO· is a gaseous molecule that can pass through lipid 
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bilayer with little difficulty, it can diffuse into mitochondria from cytosol or other sites where 
it is produced (Habib S and Ali A., 2011). Bates et al. were first to prove the existence of 
mitochondrial NOS using immunocytochemical techniques in rat brain and liver mitochondria 
(Bates T. E. et al., 1995). Mitochondrial NOS was shown to be present in cardiac 
mitochondria as well (Kanai A. J. et al., 2001). Additional oxide of nitrogen regarded as RNS 
is nitrogen dioxide (NO2
·). NO2
· is generated in reaction between NO· and O2 or when nitrite 
is oxidized by OH·. If NO2
· reacts with NO·, nitrous anhydride (N2O3) is produced (Lancaster 
J. R., 2006; Silkstone R. S. et al., 2012). NO· can further react with O2
·- to give another highly 
reactive nitrogen species, peroxynitrite (ONOO-), which is in equilibrium with its conjugated 
acid ONOOH (Balazy M and Nigam S., 2003; Habib S and Ali A., 2011). 
It is noteworthy that mitochondria not only produce ROS at the highest rate in many 
cells and tissues, but they can also stimulate production of ROS by other cellular sources like 




Figure 1. Mitochondrial production of free radicals 
 
1.2 Mitochondrial antioxidant defence 
 
 Mitochondria are a major source of ROS/RNS in the cell, hence it is not surprising 
they have so powerful and developed an antioxidant efence (Weisiger R. A and Fridovich I., 
1973; Halliwell B., 1997; Limon-Pacheco J and Gonsebatt M. E., 2009; Cardoso A. R. et al., 
2012). Several enzyme systems exist within mitochondria responsible for converting ROS 
into harmless species. At the first line of mitochondrial antioxidant defence stand Mn-SOD in 
the matrix and CuZn-SOD in the intermembrane space. Nuclear gene sod2 encodes for Mn-




-· arisen from one-electron reduction of O2 in the reaction 2O2
-· + 2H+ → 
H2O2 + O2 (Weisiger R. A and Fridovich I., 1973; Weisiger R. A and Fridovich I., 1973; 
Okado-Matsumoto A and Fridovich I., 2001).  H2O2 is also ROS, which is capable of 
damaging extramitochondrial material along with mitochondrial components. Owing to an 
uncharged character of the molecule, H2O2 can diffuse through biological membranes, which 
is most likely aided by a transporter aquaporin. Therefore mitochondrial H2O2 can freely act 
upon various extramitochondrial biomolecules (Boveris A and Cadenas E., 2000; Han D. et 
al., 2003). In recent years, however, the evidence has been rising regarding a new role of 
H2O2 as a signalling molecule. It can thus participate s a mediator of cell growth and 
apoptosis (Giorgio M. et al., 2007), in stress respon e, energy metabolism, redox balance 
(Droge W., 2002; Kowaltowski A. J. et al., 2009) and muscle differentiation (Lee S. et al., 
2011).  
H2O2 concentration in mitochondria is normally regulated by several enzymes, 
namely, catalase, glutathione peroxidase (GPX) and thioredoxin peroxidase also called 
peroxiredoxin. Catalase converts H2O2 to water and molecular oxygen. Catalase has been so 
far confirmed only in heart (Radi R. et al., 1991), brain (Drechsel D. A and Patel M., 2010) 
and liver mitochondria (Salvi M. et al., 2007). On the contrary, mitochondrial glutathione 
peroxidase is widespread among different tissues. There are two forms of mitochondrial GPX: 
matrix GPX-1 (Esworthy R.S. et al., 1997) and phospli id-hydroperoxide GPX (PHGPX, 
GPX-4) situated in the inner mitochondrial membrane (Panfili E. et al., 1991; Maiorino M. et 
al., 2003; Holley A. K. et al., 2010). Both GPXs use reduced glutathione (GSH) as a reductant 
of H2O2. PHGPX is mainly engaged in detoxification of phospholipid-hydroperoxides that 
arise in the membrane during lipid peroxidation. Another GSH dependent enzyme 
participating in lipid-peroxide detoxification in mitochondrial membrane is glutathione-S-
transferase (GST). This enzyme is also very important in metabolism of xenobiotics and in 
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this regard it is GSH that, by the action of GST, convert the reactive species derived from 
exogenous compounds to the harmless ones (Mari M. et al , 2009).  It is important to stress 
the central role of GSH in mitochondrial antioxidant defence. GSH is a tripeptide (γ-glutamyl-
cysteinyl-glycine) having a thiol-group when reduced, and which is able to give electrons to 
ROS thus becoming oxidized. The oxidized form of glutathione is glutathione disulfide 
(GSSG) (Fig. 2). GSH is synthesized in cytosol and it is transported across the outer 
mitochondrial membrane easily through porins, whereas at least two inner mitochondrial 
carriers, dicarboxylate and α-ketoglutarate enable its transport into matrix (Mari M. et al., 
2009). Mitochondrial H2O2 can be further removed by mitochondria-specific peroxiredoxin-3 
(PRX-3) that utilizes electrons from thioredoxin-2 (Trx-2), which in turn becomes oxidized. 
Reduced Trx-2 is a low molecular weight thiol-disulfide oxidoreductase and has two 
sulfhydryl groups in the active site. It also takes part in reducing oxidized cysteine groups in 
proteins directly (Stanley B. A. et al., 2011; Kudin A. P. et al., 2012). Another thiol-disulfide 
oxidoreductase present in mitochondria is glutaredoxin (Grx). Grx system is responsible for 
reducing mixed disulfides arisen from protein glutathionylation. In this case there is a 
disulfide bond between protein cysteine residue and GSH (Herrero E and de la Torre-Ruiz M. 
A., 2007). GSSG and oxidized Grx are reduced by GSH-reductase, while oxidized Trx-2 is 
reduced by thioredoxin reductase-2. Both reductases u  NADPH as a donor of reducing 
equivalents (Patenaude A. et al., 2004; Lowes D. A. and Galley H. F., 2011). Mitochondrial 
NADPH level is maintained constant mainly by three enzymes involved in its production. 
These are NADP-isocitrate dehydrogenase, malic enzyme and NADH/NADPH 
transhydrogenase. NADP-isocitrate dehydrogenase regenerates NADPH by catalysing 
oxidation of isocitrate to α-ketoglutarate using NADP+ (Dukhande V. V. et al., 2009; Yu W. 
et al., 2012). Malic enzyme, which catalyses oxidative decarboxylation of malate to pyruvate, 
is NADP+-dependant and contributes to NADPH production within mitochondria (Greco T. et 
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al., 2011). NADH/NADPH transhydrogenase is the inner mitochondrial membrane-bound 
protein that works as a proton pump. Electrochemical proton gradient (∆p) causes proton 
translocation from intermembrane space into mitochondrial matrix, which drives reduction of 
NADP+ to NADPH (Mather O. C. et al., 2004). The complete reaction catalysed by the 
enzyme is: H+out + NADH + NADP
+ ↔ H+in + NAD
+ + NADPH.  Mitochondrial 
transhydrogenase is, however, strongly product inhib ted. It is estimated that at least 45% of 
all NADPH generated in this organelle originates from this enzyme. Therefore it is a crucial 
enzyme for maintaining high NADPH/NADP+ ratio and consequently GSH/GSSG ratio in 
mitochondria. GSH/GSSG ratio is an excellent measure of oxidative stress. Furthermore, it is 
important for keeping protein thiols in reduced form. This implies its leading role for proper 
functioning of mitochondrial antioxidant defence (Rydstrom J., 2006). It is noteworthy the 
fact that mitochondrial GSH and NADPH concentrations are high, with NADPH 
concentration being approximately 3-5 mM and that of GSH 2-14 mM (Adam-Vizi V and 
Starkov A. A., 2010). Although NADPH is established mainly as indirect antioxidant, there is 
a possibility that itself can react with free radicals and thus be a direct antioxidant. De Groot 
and colleagues suggest that NADPH as well as NADH react with ONOO-, in fact with two 
radicals derived from ONOO- - carbonate radical (CO3
·-), which actually arises as a product of 
reaction of ONOO- and CO2, and nitrogen dioxide (NO2
·). The authors propose that NAD(P)H 
can react with further free radical species (Kirsch M and De Groot H., 2001). In the 
experiment conducted with cultured hepatocytes the production of 1O2 was induced, which 
readily reacted with NAD(P)H and oxidized it to NAD(P)+ (Petrat F et al., 2003).  
Apart from GSH and NADPH-dependent antioxidants, mitochondria contain some 
other ROS scavengers. These may not be as important for ormal function of the organelle as 
GSH-NADPH-linked systems, but they are certainly indispensable for thorough antioxidant 
protection. Cytochrome c, situated on the outer side of the inner mitochondrial membrane and 
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a key-component of ETC, is also considered to be a fr e radical scavenger. The oxidized form 
of cytochrome c can be reduced by O2
·- giving molecular oxygen. In this manner, a reactive 
radical is removed and the electrons from reduced cytochrome c can be passed further to 
cytochrome c oxidase. Likewise, UQH2 can scavenge a variety of ROS within membrane; 
although in its seminquinone form (UQ·) it is well established as a pro-oxidant species. 
Another well-known antioxidant compound – vitamin E (α-tocopherol), which is normally 
present in cellular membranes, hence in mitochondrial membranes as well, contributes to 
neutralizing lipid peroxides and other intermediates of lipid peroxidation process occurring in 
the membranes (Turrens J. F., 2003). Peroxyl-radicals react 1 000 times faster with α-
tocopherol than with polyunsaturated fatty acid side-chains. Thus α-tocopherol terminates 





















































1.3 Mitochondrial targets of reactive species 
 
Since mitochondria are major cellular source of ROS, it is logical that their own 
molecules become a target for ROS.  ROS along with RNS can interact, causing most often 
impairment, with virtually all macromolecules. Thus mitochondrial lipids, proteins and DNA 
are particularly susceptible to modification by ROS/RNS. One such class of lipids that are 
especially prone to oxidation by ROS is polyunsaturated fatty acids found in phospholipids. 
Mitochondrial inner membrane contains specific diphospholipid – cardiolipin (Fig. 3), which 
is an easy target of ROS caused by its unsaturated acyl chains (mostly linoleic acid) and its 
localization in the vicinity of ROS production sites (Gonzalvez F. and Gottlieb E., 2007). It is 
believed that the unaltered molecule of cardiolipin is required for the normal function of 
Complexes I and IV. Therefore, ROS can peroxidize cardiolipin, which subsequently leads to 
a decrease in the activities of these two complexes (Paradies G. et al., 2002).  
O2
·- can reversibly inactivate aconitase by oxidizing iron in iron-sulphur cluster. This 
leads to a release of Fe2+ and H2O2 that can step into reaction and generate OH
·- (Chandel N. S 
and Budinger G. R., 2007).  It can also oxidize iron of [4Fe-4S] clusters in other dehydratases, 
such as fumarase (Fridovich I., 1995). ROS is found to inhibit a few other citric acid cycle 
enzymes along with aconitase, but in somewhat different fashion. Such enzymes are for 
example succinate-dehydrogenase and α-ketoglutarate dehydrogenase. It is thought that ROS 
do not inactivate these two enzymes in a direct interaction with them, but via reversible 
glutathionylation (Nulton-Persson A. C and Szweda L. I., 2001). Complex I can promote the 
self-inactivation by O2
·- produced by this enzyme complex, which then in turn reacts with 
cystein thiol residue forming cysteinyl radical. Cysteinyl radical can react with tyrosine 
residue and thus oxidize it (Chen Y. R. et al., 2005). All these reversible inhibitions of 
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mitochondrial proteins, constituents of important biochemical pathways – citric acid cycle and 
ETC, are form of their regulation. 
Even more interesting is the interaction of RNS, namely NO· and ONOO-, with certain 
mitochondrial components. NO· is a reversible inhibitor of cytochrome c oxidase (Complex 
IV) and in this manner it plays certain role in ETC regulation. It binds to Cu2+-B centre of the 
enzyme. Other heme- and metal-containing proteins are also susceptible to nitrosylation by 
NO· (Cleeter M. W. et al., 1994; Kowaltowski A. J. et al., 2009). Furthermore, Complex I is 
the target of reversible inhibition by NO· that most likely happens via S-nitrosylation of a 
protein thiol-residue (Davis C. W. et al., 2010). On the other hand, ONOO- is a potent oxidant 
and nitrating agent that can cause irreversible damage to mitochondrial proteins.  It can 
oxidize and generate nitro-derivatives of particular amino acids, for example, cysteine, 
tryptophan, methionine, and tyrosine (Wang Y. et al., 2010). ONOO- can oxidize and nitrate 
mitochondrial phospholipids i.e. start lipid peroxidation. Particular mitochondrial proteins 
inhibited by ONOO- are Complexes I, II and IV, ATP synthase, aconitase, creatine kinase and 
Mn-SOD (Starkov A. A. et al., 2004; Jezek P and Hlavat  L., 2005). 
Finally, ROS and RNS, especially very reactive and harmful OH· and ONOO-, can 
cause damage to mitochondrial DNA (mtDNA) and, consequently, mtDNA mutations. This 
can provoke a vicious cycle, in which mtDNA mutations induce production of more ROS by 
distorted ETC that leads, eventually, to more extensive mtDNA damage. The higher 
vulnerability of mtDNA is also due in part to its location near the inner mitochondrial 
membrane, where ROS are formed. Moreover, it lacks protective histones and DNA repair 





Figure 3. Cardiolipin 
 
1.4 Lipid peroxidation  
 
ROS generated in the mitochondria and extramitochondrial sites react with various 
biological targets. Such target molecules highly sensitive to oxidative alterations by ROS 
are polyunsaturated fatty acids (PUFA) found in complex lipids e.g. phospholipids in 
cellular membranes and lipoproteins. The process where PUFA are chemically modified by 
various ROS, which leads to their degradation, is called lipid peroxidation (Girotti A. W., 
1985; van Kuijk F. J and Dratz E. A., 1987). Lipid peroxidation has been identified as a 
basic deteriorative process in cellular membranes (Trombly R and Tappel A., 1975). PUFA 
present in human lipids are, for example, essential linoleic (18:2 ω-6) and α-linolenic (18:3 
ω-3) fatty acids (Catala A., 2010). PUFA are also long-chain fatty acids belonging to ω-3 
group, such as eicosapentaenoic (EPA) (20:5 ω-3), docosapentaenoic (clupanodonic, DPA) 
(22:5 ω-3) and docosahexaenoic acid (DHA) (22:6 ω-3). In ω-6 group of fatty acids are 
also γ-linolenic (18:3 ω-6), eicostetraenoic (arachidonic, AA) (20:4 ω-6) and 
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docosatetraenoic acid (adrenic) (22:4 ω-6) (Russo G. L., 2009; Mozaffarian D and Wu J. 
H., 2011).  
Lipid peroxidation (Fig. 4) in cellular membranes is initiated by either addition of 
ROS or by hydrogen atom (allylic hydrogen) abstraction by ROS from methylene group 
between two double bonds in PUFA chain. These reactions yield a carbon-centred radical 
of PUFA. Unpaired electron can migrate between carbon atoms and it causes formation of 
conjugated dienes. Inside the membranes the concentratio  of oxygen is rather high so that 
the conjugated dienes of PUFA most often react withit and a peroxyl radical is produced.  
Peroxyl radicals are particularly reactive, especially towards neighbouring PUFA chains, 
and can remove hydrogen from them. Thus, the lipid peroxidation process is propagated. In 
this reaction a lipid hydroperoxide and carbon-centred radical are formed. Cyclic lipid 
endoperoxides may be also formed instead of lipid hy roperoxide. In the presence of 
transition metal ions (ferrous, cuprous ions) lipid eroxides can react with them yielding 
alkoxyl radicals (Halliwell B and Gutteridge J. M. C , 2007; Reed T. T., 2011). Moreover, 
the metal ions can promote destabilization of lipid peroxide molecule causing its 
decomposition to smaller products. These products are diverse, ranging from simple 
hydrocarbons to various ketones and saturated and unsaturated aldehydes. Hydrocarbons 
produced during lipid peroxidation are minor end-products and the most commonly 
measured are gaseous pentane and ethane. Pentane can result, for example, from β-scission 
reaction of alkoxyl radical. Further decomposition products of lipid peroxides, renowned 
for their reactivity and toxicity, are aldehydes such as acrolein, malondialdehyde (MDA), 
4-hydroxy-2-nonenal (HNE) (Esterbauer H. et al., 1991) and 4-hydroxy-2-hexenal (HHE) 
(Fig. 6) (Van Kuijk F. J. et al., 1990). MDA and HNE are widely used markers of lipid 
peroxidation. HNE is formed as a peroxidation product of ω-6 PUFA, such as linoleic acid, 
whereas MDA arises mainly as a product of peroxidation of PUFA with more than two 
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double bonds, such as arachidonic acid (Esterbauer H. t al., 1990; Slatter D. A. et al., 




Figure 4. Peroxidation of polyunsaturated fatty acids 
 
1.5 Lipophilic fluorescent end-products of free radical reactions  
 
The α, β – unsaturated aldehydes readily react with many biomolecules (proteins, 
amino acids, DNA, phospholipids), which results in damage of biological material. Carbonyl 
groups of aldehydes react with amino groups of the biomolecules forming Schiff bases (Niki 
E., 2009). Finally, relatively stable chloroform extractable lipophilic fluorescent end-products 
are formed (Chio K. S and Tappel A. L., 1969; Yin D, 1995). Tappel and colleagues (Chio K. 
S and Tappel A. L., 1969) were first to demonstrate that lipid peroxidation product – 
malondialdehyde (MDA), in reaction with free amino groups, produces the fluorescent 
pigments. The end-products were initially named lipofuscin-like pigments (LFP) on the basis 
of the similarity of their fluorescence properties with those of lipofuscin - the pigment of old 
age (Chio K. S. et al., 1969). The most studied aldehy es participating in fluorescent end-
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product formation are HNE and MDA (Del Rio D. et al., 2005; Catala A., 2009). 
Fluorophores, produced by cross-linking amino groups with carbonyl moieties of reactive 
aldehydes, represent a mixture of numerous compounds of known and unknown chemical 
structure. The fluorescent pigments showing representative lipofuscin-like fluorescence of 
known structure or at least of known origin have ben best characterized and described in 
experiments where they were formed in vitro by incubating aldehydes derived from lipid 
oxidation (MDA, HNE) with compounds having a free amino group (Fig. 5). Similarly, 
compounds with primary amino group can be incubated with PUFA itself or PUFA 
containing phospholipids in order to analyse arising fluorophores (Wang J. Y. et al., 1996). 
Fluorescent compounds produced in model reactions in vitro with known and unknown 
chemical structure have been analysed in order to gain an insight into mechanism of their 
formation. Trombly and Tappel prepared such fluorescent products in reaction between 
arachidonic acid and synthetic phospholipid - dipalmitoyl phosphatidyl etahanolamine (PE), 
being irradiated with UV light to initiate free radical formation, as well as by mixing MDA 
and PE.  They determined excitation maxima of the products, which were at wavelengths 260 
nm and 365 nm, and one emission maximum at 430 nm. The fluorescence observed here lies 
within interval typical for lipid peroxidation end-products (Trombly R and Tappel A., 1975). 
In similar in vitro experiments Deng and colleagues synthesized fluorescent products in direct 
reaction of MDA with biological amines e.g. gamma-aminobutyric acid and taurine. In 
addition, they confirmed a structure of lipofuscin-like fluorescent product – 1,4-
dihydropyridine, which was detected by means of HPLC. Besides that, these findings also 
show the scavenging properties of various biological amines on reactive aldehydes formed 
during lipid peroxidation. The amines can attenuate reactive aldehydes' harmful effect as they 
are able to compete for aldehyde carbonyl groups with amino groups of important 
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macromolecules, thus preventing protein adduct and cross-link formation (Deng Y. et al., 
2011; Deng Y. et al., 2012). 
In another experiment MDA was incubated with pyridoxamine (PM), which yielded 
three different products analysed by HPLC and LC-MS: 1-amino-3-iminopropene, 1-
pyridoxamino-propenal and a dihydropyridine-pyridinum complex. Dihydropyridine-
pyridinium derivative and dihydropyridine are end-products showing typical lipofuscin-like 
fluorescence. The same authors incubated bovine serum albumin with MDA, which resulted 
in formation of fluorescent products with fluorescen  similar to dihydropyridines, and whose 
intensity was decreased when PM was added, clearly indicating that PM can inhibit, to some 
extent, the reaction of MDA with proteins (Kang Z. et al., 2006). 
Slatter et al. found that the principal product of he reaction of MDA and propylamine 
is a stable dihydropyridine derivative, namely N-propyl-4-methyl 2,6-dihydropyridine 3,5-
dicarbaldehyde. Likewise, if protein lysine residue, whose amino group is most reactive 
towards aldehydes, reacts with MDA the product is N-lysyl-4-methyl 2,6-dihydropyridine 3,5-
dicarbaldehyde. Additionally, the aldehyde side-chains on the dihydropyridine ring can 
further react with other amino groups to form protein cross-links. Similarly, protein amino 
groups other than those of lysine can directly react with MDA to form adducts (Slatter D.A. et 






Figure 5. The production of fluorescent LFP 
 
Another reactive aldehyde formed during lipid peroxidation, HNE, is also responsible 
for production of fluorescent compounds in reactions with amino groups.  It has been found 
that HNE forms a fluorescent hydroxyiminodihydropyrrole derivative with the amino group 
of lysine residue in oxidized low-density lipoprotein (Itakura K. et al., 2000). In another 
study, where in a model reaction lysine derivative was exposed to autoxidation of linoleic 
acid, a fluorophore with hydroxyiminodihydropyrrole structure was produced. The 
fluorophore was analysed by HPLC with fluorescence d tection (360/430 nm 
excitation/emission). HPLC analysis revealed two different products, one being lysine 
derivative-HNE adduct, while the second adduct was made of another lipid peroxidation 
product, 9-hydroxy-12-oxo-10-dodecanoic acid, and the lysine derivative. This finding was 
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confirmed by LC-MS analysis (Itakura K and Uchida K., 2003). Riazy et al. described lipid 
peroxidation end-products formed by addition of unfragmented oxidation products of 
arachidonic and linoleic acid, probably being unfragmented aldehydic products, 
hydroperoxides or endoperoxides, onto amino groups of proteins and phospholipids.  On 
analysing these adducts by MS/MS the authors found that some of the arachidonic acid-
derived lysine-adducts were isolevuglandins containing lactam and hydroxylactam rings. The 
fluorescence maxima for these products were 360 nm for excitation and 430 nm for emission 
(Riazy M. et al., 2011). These findings point out that not only decomposition products of 
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1.6 LFP as markers of oxidative stress in model systems  
 
LFP are nowadays mainly used as indicators of oxidative stress. As relatively stable 
end-products of lipid peroxidation, LFP are good markers of a free radical production and of 
consequent damage of lipids. Moreover, they are used not only as markers of lipid 
degradation but also to estimate amino acid or protein loss due to cross-linking. So far, LFP 
have been mostly used as robust markers of oxidative damage without defining specific 
chemical identity of compounds representing these pigments. In such cases, the fluorescent 
pigments are simply markers of free radical production under different circumstances.  
Free radical production and oxidative damage in biolog cal systems, caused by various 
triggers, were assayed by measuring LFP in many studies. Hypoxia, hyperoxia and 
ischemia/reperfusion are accompanied with increased pro uction of free radicals and LFP 
were used as markers of oxidative damage (Wihlmark U. et al., 1996; Wilhelm J and Herget 
J., 1999; Siskova A and Wilhelm J., 2001; Ostadalov I. et al., 2007). Elevated LFP 
concentrations were found in erythrocytes and spleen from rats exposed to hypoxia for 
different time periods when compared with animals that had been kept at normoxic conditions 
(Wilhelm J and Herget J., 1999). Measurement of LFP concentration proved to be useful 
when assessing antioxidative property of different potential antioxidants (Ostadalova I. et al., 
2007; Skoumalova A. et al., 2008).  Furthermore, LFP were used as indicators of oxidative 
stress induced by physical activity (Vasankari T. et al., 1995), phagocytosis of oxidized 
proteins (Shimasaki H. et al., 1995) and ionizing radiation (Wilhelm J and Sonka J., 1980; 
Wilhelm J and Sonka J., 1980; Wilhelm J and Sonka J., 1981; Wilhelm J and Sonka J., 1981; 
Wilhelm J and Sonka J., 1982; Rejholcova M and Wilhelm J., 1986; Rejholcova M and 
Wilhelm J., 1989; Wilhelm J. et al., 1989). LFP were analysed in various tissues and cell 
compartments of rats exposed to radiation such as liver homogenates and mitochondria 
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(Wilhelm J and Sonka J., 1981), (Wilhelm J and Sonka J., 1980; Wilhelm J and Sonka J., 
1982), skeletal muscles (Wilhelm J and Sonka J., 1980), erythrocytes (Wilhelm J. et al., 
1989), spleen (Wilhelm J. et al., 1989) and adipose tissue (Rejholcova M and Wilhelm J., 
1986; Rejholcova M and Wilhelm J., 1989). There arelso studies where, for example, 
erythrocyte ghosts or mitochondria were peroxidized in vitro using different triggers of free 
radical production (ferrous ions and ascorbic acid) or incubated with lipid peroxidation 
intermediates (MDA), in order to study the mechanisms of LFP formation or to assess the 
extent of radical-mediated damage (Wilhelm J. et al., 2005; Skoumalova A. et al., 2008; Ivica 
J. et al., 2011; Skoumalova A. et al., 2012).  Low-density lipoprotein, which plays 
undoubtedly a very important role in atherosclerotic lesion formation, has been also 
extensively studied as a model protein, with regard to its oxidation and forming fluorescent 
adduct on the protein amino groups (Itakura K et al., 2000; Riazy M. et al., 2011). As it has 
been mentioned before, lipofuscin is the ageing pigment and it accumulates as a normal part 
of senescence. On the other hand, LFP are produced as a result of oxidative stress, which is 
connected with pathological processes. LFP are known t  be involved in ageing and diseases 
related to it e.g. neurodegenerative and heart diseases. Hence, LFP are a potential marker of 
oxidative damage to biological material due to increased ROS production in aged subjects. In 
one such study, LFP were used as a tool to assess th  extent of ROS formation in brain cortex 
of rats during early postnatal development. The highest accumulation was found immediately 
after birth and the levels were falling until three months from birth, which is believed to be a 
period when ageing starts in rats (Wilhelm J. et al., 2011). LFP were also used in an 
experiment conducted on dogs diagnosed with canine counterpart of senile dementia of 
Alzheimer’s type as one of the markers of lipid peroxidation, which has been proposed to take 
part in pathogenesis of this condition (Skoumalova A. et al., 2003). Sen et al. measured 
fluorescent lipid peroxidation end-products as markers of ageing in rat brains. Aged rat brains 
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had considerably increased accumulation of end-products compared to those from young 
animals (Sen T et al., 2007). Davydov and Shvets analysed lipid peroxidation products, with 
LFP being one of them, in the heart of adult and old rats exposed to stress to assess whether 
myocardium becomes less resistant against stress at old ge (Davydov V. V and Shvets V. N., 
2001). LFP were also measured in brain of rats exposed to lead in order to investigate possible 
mechanism of lead toxicity and its role in oxidative stress in brain (Patkova J. et al., 2012). 
 
1.7 Application of LFP analysis in biomedicine 
                                                                                                                                                                                                               
Since LFP are markers of oxidative damage of lipids and other molecules caused by 
ROS, their measurement may be a useful tool for monitori g pathological processes linked 
with oxidative stress. ROS overproduction, which leads to impairment of biological 
molecules, underlies the pathophysiological mechanism of many diseases. The most common 
disorders, whose developments ROS contribute to, are neurodegenerative diseases e.g. 
Alzheimer’s disease (Lassmann H., 2011), Parkinson’s disease (Schapira A.H., 1995) and 
multiple sclerosis (Lassmann H., 2011), atherosclerosis and other vascular diseases 
(Sugamura K and Keaney J.F., 2011), cancer (Klaunig J.E. et al., 2011) and diabetes (Victor 
V.M. et al., 2011). 
The role of ROS in pathogenesis of Alzheimer’s disease (AD) has been widely 
accepted as there is a strong evidence for it in scientific literature. ROS production exceeding 
their removal by antioxidant mechanisms leads to oxidative injury in AD brain. PUFA from 
brain phospholipids are notably prone to oxidation and there are several studies pointing that 
lipid peroxidation is increased in AD patient compared with healthy subjects (Montine T. J. et 
al., 1999; McGrath L.T. et al., 2001). There have be n described fluorophores, identified as 
HNE-adducts with pyrrole structure, in neurons and lesions of AD subjects (Zhu X. et al., 
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2012).  Inasmuch as LFP are end-products of lipid peroxidation, they might be used as 
specific markers of AD. In a study by Skoumalova and colleagues, LFP extracted from red 
blood cells of patient with AD and their age-matched controls were analysed in order to find a 
diagnostic marker easy to measure since blood samples can be routinely taken. There was 
found an increase in LFP formation, measured by means of fluorescence, in patients 
diagnosed with AD when compared with controls. As particular fluorophores, obtained by 
fluorescence measurements, represent a mixture of different compounds they were 
subsequently resolved into distinctive fractions by HPLC. Chromatograms from these two 
groups revealed a difference in LFP composition betwe n them (Skoumalova A. et al., 2011). 
Another neurodegenerative disease linked with oxidative stress is multiple sclerosis. Yet the 
relation between oxidative stress and progression of disability in multiple sclerosis is still 
unclear. Therefore, Koch and colleagues attempted to assess this relation using LFP as a 
marker of oxidative stress. LFP was measured in plasma from patients with different disease 
course of multiple sclerosis and healthy controls. LFP levels were increased in patients with 
multiple sclerosis, comparing to controls, but the authors failed to prove the relation between 
oxidative stress and disease course and progression (Koch M. et al., 2007). 
Vascular diseases characterized by formation of atherosclerotic lesions are associated 
with oxidative stress. ROS overproduction leads to increased oxidation of low-density 
lipoprotein, endothelial dysfunction and vascular smooth muscle cell proliferation, which 
promotes progression of atherosclerotic events (Madamanchi N.R and Runge M. S., 2007; 
Puddu P et al., 2009). Coronary heart disease (CHD) is featured by accumulation of 
atherosclerotic plaques and their subsequent rupture in coronary arteries that supply 
myocardium with oxygen and nutrients. Among other parameters that predict disease 
development and progression, lipid peroxidation products malondialdehyde and fluorescent 
end-products are ones that are frequently utilized (Rao V and Kiran R., 2011). Wu et al. 
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carried out clinical studies using fluorescent LFP as potential markers of oxidative stress. LFP 
were measured in plasma from individuals participating in the epidemiological studies to 
evaluate their ability to predict development of CHD as well as to assess their potential as a 
global marker of oxidative stress in this type of studies. It was found that high levels of 
fluorescent products were significantly associated with incidence of CHD among individuals 
without previous cardiovascular events. Furthermore, th se markers were found to be an 
independent risk factor for CHD. The same authors cncluded that LFP measured in plasma 
could be a useful marker of oxidative stress for large epidemiological studies (Wu T. et al., 
2007; Wu T.et al., 2007). Tertov et al. measured LFP in normal and atherosclerotic areas of 
human aorta to deepen the knowledge about atherogenesis and the development of advanced 
lesions in arterial walls. The level of fluorescent LFP, measured at 360/430 nm 
(excitation/emission), did not differ remarkably betw en normal intima and initial lesions. 
Nevertheless, there was a significant rise in LFP level from atherosclerotic plaques compared 
to unaffected intima. In addition, it was found that LFP content in lipid extracts from the 
media underlying normal intima and initial lesions was similar, whereas it was significantly 
higher in extracts from the media underlying advanced atherosclerothic lesions (Tertov V.V. 
et al., 2001). Gu and colleagues reported a potential usefulness of a specific lipid peroxidation 
product, omega-(2-carboxyethyl) pyrrole, as a marker for prediction of development of age-
related macular degeneration. This protein adduct is formed from product of free-radical 








2. DESIGN OF STUDY 
 
 The aim of this study was to test the hypothesis that fluorescent end-products of free 
radical reactions, the so called lipofuscin-like pigments (LFP), might represent a new 
metabolome with medically important properties. 
 For that purpose we studied in a great detail the kin tics of formation of lipofuscin-like 
pigments in beef heart mitochondria exposed in vitro to various reactive oxygen and reactive 
nitrogen species. LFP were characterized by spectrofluo metric techniques and we 
developed new HPLC separation procedures to resolve individual fluorescent species.  
 As the next step of this study we evaluated the potential of LFP as markers of 
oxidative damage in various cells and tissues. LFP were analysed during early development of 
rat brain and in erythrocytes from patients with Alzheimer’s disease. 
 As a result, we were able to resolve several tens of individual fluorescent species and 
confirmed the existence of a new metabolome of related compounds that participate in the 








3. MATERIALS AND METHODS 
3.1 Experimental material 
3.1.1 Isolation of mitochondria 
 
Mitochondria from beef heart were isolated according to the procedure described by 
(Haas D. W and Elliott W. B., 1963) with some modifications. Throughout the whole 
experiment all the materials used for isolation were kept on ice. The preparation of 
mitochondria was carried out within few of the hours after slaughter of cow. Firstly, beef 
heart was cut into smaller pieces, which were ground a d homogenized. For homogenization, 
buffer solution consisting of 0.05 M Tris, 0.9 % NaCl and 0.001 M EDTA, pH 7.4 adjusted 
with HCl was used. Homogenized heart was then filtered through cheesecloth and the filtrate 
was collected for mitochondria isolation. Mitochondria were isolated by differential 
centrifugation. Homogenate was centrifuged twice at 2000 × g for 10 min and the precipitate 
was thrown away. Supernatant, which was being colleted, was centrifuged at 16 000 × g for 
10 min and mitochondria were precipitated. Mitochondrial sediment was again dissolved in 
Tris buffer. Reconstituted mitochondria were once more centrifuged at 16 000 × g for 10 min 
and the sediment dissolved in Tris buffer. Mitochondria were then frozen and kept at -20°C. 
Small amount of mitochondria was taken for protein assay by Lowry’s method (Lowry O. H. 







3.1.2 Rat brain homogenates 
 
A total of 70 pregnant female Wistar rats were used throughout the experiments. 
They had free access to water and standard laboratory diet. The offspring of both sexes were 
divided into 10 groups. Group A (110 fetuses) was smpled 7 days before birth, group B 
(110 fetuses) 1 day before  birth, group C (50 animls) on postnatal day 1, group D (50 
animals) on postnatal day 2, group E (50 animals)  on  postnatal  day  5,  group  F  (50  
animals)  on postnatal day 10, group G (50 animals) on postnatal day 15, group H (30 
animals) on postnatal day 25, group I (30 animals) on postnatal day 35, and group J (20 
animals) 3 months  after  birth.  The animals were uthanized by decapitation in ether 
narcosis. The frontal brain was rapidly removed, separated from white matter if possible, 




Male and female subjects with established clinical di gnosis of “probable Alzheimer's 
disease” according to NINCDS-ADRDA criteria (McKhann G. et al., 1984), and with history 
of symptoms of Alzheimer’s disease for at least 6 months, and with Mini Mental State 
Examination (MMSE) (Folstein M. F. et al., 1975) score ≤ 24/30 points (N=44) and age-
matched controls (N = 16) from out-patient memory clini  and in-patient of the Department of 
Geriatric Medicine, the General Faculty Hospital and First Faculty of Medicine of the Charles 
University in Prague were selected. For the study, 5 mL of heparinized blood samples were 
obtained centrifuged, and the erythrocyte sediment was used for analysis. All samples were 
anonymously coded. The Ethics Committee of the General Faculty Hospital in Prague 
approved the study. 
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3.2 In vitro peroxidation of mitochondria 
3.2.1 In vitro peroxidation with iron – ascorbic acid system 
 
Mitochondria were incubated with FeSO4, ascorbic acid and EDTA for up to 48 h. 
Incubation mixture consisted of mitochondria at protein concentration 1.5 mg/mL, 0.1 M 
phosphate buffer pH 5.5, 0.33 mM FeSO4, 3.33 mM ascorbic acid and 1.7 mM EDTA 
(Wilhelm J., 1983). Once the incubation mixture had been made, aliquots were taken exactly 
after 0, 1, 2, 4, 6, 24 and 48 h for TBARS and lipofuscin-like pigments measurements. In vitro 
incubations were performed at 25 ºC and 37 ºC. 
 
3.2.2 In vitro peroxidation with malondialdehyde  
 
Mitochondria were incubated with MDA (Fig. 7) for up to 48 h. Each incubation 
mixture consisted of mitochondria at protein concentration 1.5 mg/mL, 0.1 M phosphate 
buffer pH 5.5 and lipid peroxidation product MDA at the concentration 100 µM. Once the 
incubation mixture had been made, aliquots were takn exactly after 0, 1, 2, 4, 6, 24 and 48 h 
for lipofuscin-like pigments measurements. In vitro incubations were performed at three 









3.2.3 In vitro peroxidation with tert-butylperoxide  
 
Mitochondria were incubated with tert-BuOOH (Fig 8.) for up to 48 h. Each 
incubation mixture consisted of mitochondria at protein concentration 1.5 mg/mL, 0.1 M 
phosphate buffer pH 5.5 and generator of free radicals tert-BuOOH at the concentration 100 
µM. Once the incubation mixture had been made, aliquots were taken exactly after 0, 1, 2, 4, 
6, 24 and 48 h for lipofuscin-like pigments measurements. In another experiment 
mitochondria were incubated in 0.1 M phosphate buffer, pH 7.4 with higher concentrations of 
tert-BuOOH that were 200 µM and 1 mM for 24 h. The mitochondrial protein concentration 
was 10 mg/mL. The aliquots were taken exactly after 0, 1 and 24 h for lipofuscin-like 
pigments measurements. 
 
Figure 8. Tert-butylhydroperoxide 
 
 
3.2.4 In vitro peroxidation with peroxynitrite 
 
Mitochondria were incubated in 0.1 M phosphate buffer, pH 7.8 with two different 
concentrations of ONOO- for 24 h. The concentrations of ONOO- in incubation mixtures were 
2 mM and 4 mM and the mitochondrial protein concentration was 10 mg/mL. The aliquots 






3.3 Fluorescence measurement of lipofuscin-like pigments 
 
LFP from mitochondria incubated with iron – ascorbic acid system, tert-BuOOH, 4-
HNE, MDA and ONOO- were measured according to the modified method described by 
Goldstein B. D and McDonagh E. M., 1976 and Wilhelm J and Herget J., 1999. 4 mL of 
chloroform-methanol mixture (2:1, v/v) was added to 0.5 mL of mitochondrial suspension and 
let for extraction of lipophilic LFP on a motor-driven shaker for one hour. After that, 2 mL of 
distilled water was added and the samples were vigorously mixed. The mixture was 
subsequently centrifuged for 10 min at 2000 × g andthe lower chloroform phase was 
separated from aqueous phase and used for measurements. The same procedure for lipophilic 
LFP extraction was used in the experiment with rat b in homogenates. Approximately 30 mg 
of frozen brain sample was weighed, chopped to fine pieces, and transferred into a glass-
stoppered test tube containing 6 mL of chloroform – ethanol mixture (2:1, v/v). For the 
extraction of LFP from red blood cells chloroform – isopropanol mixture (3:2, v/v) was used. 
 LFP fluorescence was measured on Aminco-Bowman Series 2 spectrofluorometer. 
Tridimensional excitation spectra and synchronous excitation spectra were measured using 
AB-2 computer program. Tridimensional excitation spectra were measured in the range of 
250-400 nm for emission set between 320 and 510 nm with a step of 10 nm. As for 
synchronous spectra from mitochondrial extracts, the excitation wavelengths were measured 
in the range 300-500 nm and the difference between excitation and emission was set 50 nm, 
so that emission was measured in the range 350-550 nm. Synchronous spectra from 
erythrocyte extracts were measured in the excitation range 250-500 nm with the constant 




 The spectrofluorometer was calibrated with 130 µM quinine hemisulfate in 0.05 M 
H2SO4 and fluorescence was expressed in relative units (RFU) per mg of protein. The 
fluorescence maxima were always read from tridimensional spectral arrays. 
 
3.4 TBARS measurement 
 
Thiobarbituric acid-reactive substances (TBARS) were measured using the method 
described by Vazquez-Memije et al. (2008). 500 µL of 40 % trichloracetic acid was added 
into suspension containing 500 µL of mitochondria and it was centrifuged at 4000 × g for 10 
min. Afterwards, 300 µL of supernatant was mixed with 750 µL of 1 % thiobarbituric acid 
dissolved in 50 mM NaOH and let stand at 90 °C in a bath for 30 min. After cooling, 2 mL of 
butanol was added into a test-tube, centrifuged at 2000 × g for 10 min and the extracted 
TBARS were measured in upper butanol phase at 532 nm on spectrophotometer (Helios λ, 
Thermo Electron Corporation). Concentrations were calculated using calibration curve made 
with malondialdehyde standard. 
  
3.5 LFP analysis by reverse phase high-performance liquid 
chromatography (RP-HPLC) 
 
Specific fluorophores obtained by tridimensional and synchronous excitation spectral 
measurements were further analysed by RP-HPLC with isocratic or gradient elution. The 
separation of fluorophores was carried out on HPLC instrument equipped with pump (PU-
2080, Jasco), auto-sampler (AS-2055, Jasco) and fluorescence detector (FP-2020, Jasco). 
When gradient elution was used another pump (PU-2080, Jasco) and mixer (MX-2080-32) 
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were applied in analysis. The columns used in the experiments were C18 columns typical for 
reverse phase HPLC: TC-C18(2) column (4.6 x 250 mm, 5 µm) Agilent, USA; Separon C18 
column (4 x 250 mm, 5 µm), Tessek, Czech Republic.   Fluorescence wavelengths set on the 
detector were actually fluorescence maxima obtained from 3D and synchronous spectra. 
 
3.5.1 HPLC analysis of LFP from rat brain 
 
Firstly, LFP were extracted from samples of frontal p rt of rat brains previously 
removed from either animal fetuses or born animals. The samples were collected seven days, 
and one day before birth, and on day 1, 2, 5, 10, 15, 25, 25 and 90 after birth. Extracted LFP 
(Wilhelm J. et al., 2011) were measured by means of spectrofluorometry. Fluorescence 
maxima of particular fluorophores analysed by HPLC were obtained from 3D and 
synchronous spectral arrays. 
 Brain chloroform extracts were evaporated under vacuum and the samples were re-
dissolved in approximately 1 mL of mobile phase. For is cratic separation C18 column (4 × 
250 mm, 5 µm) was used. Mobile phase consisted of acetonitrile (ACN) – methanol (MeOH) 
– water mixture in different volume ratios. Several different mixtures with different polarities 
were used as mobile phases to test which would give the most satisfactory resolution. Mobile 
phases examined in the experiment were ACN – MeOH – H2O (50:10:40, v/v), ACN – MeOH 
– H2O (30:10:60, v/v), ACN – MeOH – H2O (50:10:50, v/v) and ACN – MeOH – H2O 
(50:10:60, v/v). Three major fluorophores (F325/380, F335/410 and F355/440) were resolved 
into fractions by HPLC with corresponding excitation/emission values set on detector. Sample 
volume injected in the analyses was 10 µL and the optimal separation was achieved with 0.2 




3.5.2 HPLC analysis of LFP from erythrocytes 
 
Erythrocytes were isolated from blood withdrawn from patients with Alzheimer’s 
disease and subjects with normal cognitive functions labelled as controls. LFP from 
erythrocytes were extracted according to the method of Goldstein and McDonagh (1976) and 
measured spectrofluorimetrically using 3D and synchronous spectral analysis. Chloroform 
extracts were evaporated under vacuum and the samples were re-dissolved in approximately 1 
mL of mobile phase that consisted of a mixture of ACN – MeOH – H2O (50:10:40, v/v). The 
analysis was performed in isocratic mode. Four distinctive fluorophores (F350/440, F285/310, 
F330/380 and F335/360) were analysed and resolved into fractions. The C18 column (4 × 250 
mm, 5 µm) was used and the flow rate was 0.2 mL/min. Additionally, F285/310 was also 
resolved with 0.4 mL/min flow rate. 20 µL of each sample was injected for analysis, which 
was performed at 25 °C. 
 
3.5.3 HPLC analysis of LFP from mitochondria  
 
3.5.3.1 Isocratic HPLC  
 
LFP from mitochondria incubated with tert-BuOOH were analysed by isocratic 
chromatographic technique. Many different mobile phases, composed of various volume 
ratios of ACN – MeOH – H2O mixture, had been tested before the optimal solvent mixture 
was found. The percentage of water in mobile phase r nged from 20 - 70 % as well as various 
ratios of organic solvents were tested. Furthermore, different mobile phases that contained 
only ACN/water or MeOH/water mixtures were also tried out when optimal solvent 
43 
 
composition for LFP separation was sought. In this ca e percentage of water in mobile phase 
was from 50 – 70 %. We also employed a test of how an acidic mobile phase would affect 
separation of the complex mixture of lipophilic pigments by adding 1 % acetic acid to 
aqueous phase. It did not show any improvement on separation. Different flow rates were also 
examined (0.3 – 0.6 mL/min) in order to find the most appropriate one. Eventually, mobile 
phase ACN – MeOH – H2O (20:40:40, v/v) and the flow rate 0.4 mL/min were chosen for the 
analysis as they gave the most acceptable separation of individual peaks. Four major 
fluorophores (F350/440, F310/440, F340/390, F360/410), found as maxima in fluorescence 
spectra, were resolved into fractions on C18 column (4 × 250 mm, 5 µm) using 30 µL of 
samples. All analyses were performed at 25 °C. Furthermore, F350/440, which had maximal 
fluorescence in 3D spectra, was analysed by mobile phase ACN – H2O (60:40, v/v) on TC-
C18(2) column (250 × 4.6 mm, 5 µm). In this analysis we tested how the amount of sample 
injected affects separation of individual peaks. After testing several different injection 
volumes (1 – 30 µL) we chose 3 µL of sample to apply in the analysis. The flow rate was 0.5 
mL/min. All analyses were performed at 35 °C. 
 LFP from mitochondria incubated with MDA were analysed by isocratic 
chromatographic technique. LFP obtained by incubating mitochondria with MDA were 
resolved with several mobile phases. In search for go d separation conditions we again tested 
several different running phases. Thus, ACN – MeOH – 2O (20:40:40, v/v) was used, as it 
proved to be rather good in previous experiments. In addition, mobile phase composed of 
ACN and distilled water mixed in different ratios was tested and the ACN volume fraction 
used for the analysis was 30 - 80 %. The most satisfac ory separation was obtained with 40 % 
and 60 % ACN, with respect to analysed samples. Separation was done on TC-C18(2) column 
(250 × 4.6 mm, 5 µm), but apart from the standard C18 column used in our measurements C8  
(4 × 250 mm, 5 µm) column was also tested. A different separation pattern and improvement 
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were not observed when this type of column was used. R garding the injection volume, the 
low ones (1-10 µL) were tried out and the volume of 5 µL was accepted for analysis.  The 
flow rate of mobile phase was 0.5 mL/min and one fluorophore (F350/440) was measured. 
This was found as maximal fluorescence in 3D spectra. All measurements were performed at 
30 °C. 
 
3.5.3.2 Gradient HPLC  
  
LFP extracted from beef heart mitochondria as well as from peroxidized mitochondria 
with tert-BuOOH or ONOO- were analysed by means of chromatography with gradient 
elution. To develop a good method for separation of complex mixture of different compounds 
comprising individual fluorophores found in 3D and differential spectra, it was necessary to 
find appropriate solvents and to establish their optimal mixing throughout analysis. Polar 
solvent used in the analyses was ACN/water, MeOH/water or isopropanol/water mixture, 
while the non-polar solvent was pure ACN, MeOH or isopropanol. Organic solvent was 
mixed with distilled water in various ratios, which ranged from 5 – 40 % of the solvent in the 
mixture. Analysis was started with 10 % of non-polar solvent, running for 5 min in isocratic 
mode, and then it continued to run in gradient mode until 100 % non-polar solvent was 
achieved. Duration of analysis, which was subject to change, determined the rate of solvent 
composition change from 10 % to the final 100 % of n n-polar solvent. Several flow rates had 
been considered before one was chosen for analysis of all samples. I tested 0.4 mL/min, 0.7 
mL/min and 1 mL/min flow rates. Similarly, injection volumes 0.5 µL, 1 µL, 5 µL, 10 µL and 
20 µL were tested. All analyses were performed at 30 °C. After various combinations had 
been tested during the search for optimal separation conditions, one method that proved to be 
the most convenient was chosen for analysis of the samples. In both experiments, i.e. with 
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tert-BuOOH and ONOO- the same methods were used. The difference was in excitation and 
emission wavelengths set at the detector, since the fluorescence maxima were different. In the 
experiment with tert-BuOOH the fluorescence was set at 360/430 nm, 380/460 nm and 
460/517 nm. In the experiment with ONOO- the excitation/emission wavelengths adjusted on 
detector were: 355/430 nm, 358/500 nm and 360/450 nm. The separation conditions were as 
follows: polar solvent (A) was 8 % ACN in water and on-polar solvent (B) was 100 % ACN. 
The analysis time was 25 min. The chromatographic analysis began with the following 
solvent composition: 90 % A, 10 % B. This solvent composition ran in isocratic mode for 5 
min. After fifth minute gradient mode was used, in which composition of solvent B changed 
from 10 % to 75 % until 25 min when the analysis was ended. Between two analyses the 
column was equilibrated with the starting mobile phase (10 % B) for 10 min. The chosen flow 
rate was 0.7 mL/min and the injection volume was 20 µL. Inasmuch as the fraction of interest 
eluted from the column when the percentage of solvent B was in the range 40 – 50 %, further 
analysis was performed with this particular solvent composition in order to seek better 
separation. Therefore, the chromatographic analysis was running for 5 min in isocratic mode 
with 40 % B mobile phase and further continued from the fifth minute to 25th minute in 
gradient mode. During the gradient chromatographic analysis the mobile phase composition 












4.1 In vitro lipid peroxidation of mitochondria wit h iron – ascorbate system 
 
4.1.1 LFP fluorescence measurements  
 
In this experiment the kinetics of in vitro lipid peroxidation of isolated beef heart 
mitochondria with iron – ascorbate system and its dependence on temperature were studied. 
The kinetics of lipid peroxidation was assessed by analysing fluorescent end-products of the 
process. The measurements were performed at 25 °C and 37 °C. The mitochondria were 
incubated with generators of free radicals for 48 h. 
The pronounced production of LFP from mitochondria incubated with iron – ascorbic 
acid system at 25 °C, which was assessed by 3D excitation spectra, was observed in samples 
taken from incubation mixture after 24 h and 48 h from the beginning of the experiment (Fig. 
9). The 3D spectral arrays reveal fluorescence maxium at 350/470 nm (excitation/emission) 
in the sample incubated for 24 h, whereas after 48 h a shift in fluorescence maximum was 
observed as the emission maximum observed here was 420 nm. Other peak excitation 
wavelengths were found at 308 nm and 305 nm in 24 h and 48 h incubation samples, 
respectively.  
In the experiment carried out at 37 °C the increased production of LFP was seen in the 
samples incubated for 24 h and 48 h (Fig. 10). 3D spectral array shows that the maximum 
excitation wavelength is within interval 305-310 nm for 24 h sample, with another excitation 
maximum in the range 350-360 nm. For both excitation ranges the maximum emission 
observed is 460 nm. 3D spectral array of the 48 h sample reveals two excitation maxima, one 
of them being again in the range 305-310 nm and the o r at 340-360 nm. However, the 
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emission maxima for these excitation wavelengths are shifted to 430 nm, when compared 
with 24 h sample.  
The synchronous excitation spectra of the two samples have the shape that is changed 
when compared with the control sample (0 h) in the both experiments, where the fluorescence 
maxima are shifted towards lower emission wavelengths. In the course of in vitro 
peroxidation of mitochondria for up to 48 h, there is not only a higher production of LFP, but 
there is also a change in composition and the ratioof individual fluorophores. 
In both experiments there was a measurable increase in LFP concentration after 24 h 
of incubation. After 48 h there was even greater inc ease observed. From the shapes of 3D 
spectral arrays it is apparent that during the time course of lipid peroxidation the composition 
of fluorescent LFP changes. In both experiments synchronous spectra show the alteration in 
relative composition of fluorophores in samples 24 h and 48 h when compared to 0 h. In the 
experiment carried out at 37 °C (Fig. 11) a slight increase in fluorescence in sample 48 h is 





Fig. 9. Tridimensional fluorescence spectral arrays of extracts of beef heart mitochondria 
incubated with 0.33 mM FeSO4 and 3.33 mM ascorbic acid at 25 °C. The panel A represents 
the sample obtained after 24 h of incubation and the panel B represents the sample obtained 




Fig. 10. Tridimensional fluorescence spectral arrays of extracts of beef heart mitochondria 
incubated with 0.33 mM FeSO4 and 3.33 mM ascorbic acid at 37 °C. The panel A represents 
the sample obtained after 24 h of incubation and the panel B represents the sample obtained 




Fig. 11. Synchronous excitation spectral arrays of extracts of beef heart mitochondria 
incubated with 0.33 mM FeSO4 and 3.33 mM ascorbic acid at 25 °C. The panel A represents 
the sample obtained after 0 h of incubation, the panel B represents the sample obtained after 
24 h of incubation and the panel C represents the sample obtained after 48 h of incubation. 





Fig. 12. Synchronous excitation spectral arrays of extracts of beef heart mitochondria 
incubated with 0.33 mM FeSO4 and 3.33 mM ascorbic acid at 37 °C. The panel A represents 
the sample obtained after 0 h of incubation, the panel B represents the sample obtained after 
24 h of incubation and the panel C represents the sample obtained after 48 h of incubation. 




4.2 Incubation of mitochondria with lipid peroxidation product 
malondialdehyde 
 
4.2.1 LFP fluorescence measurements  
 
The kinetics of LFP formation in isolated beef heart mitochondria incubated with 
MDA and its dependence on temperature were studied in this experiment. The measurements 
were performed at 25 °C, 37 °C and 50 °C. The mitochondria were incubated with MDA for 
48 h. 
In the experiment performed at 25 °C 3D spectra revealed the production of LFP only 
after 48 h of incubation. In other samples LFP production was not observed. Maximum 
fluorescence in 48 h sample was found at 350/440 nm (excitation/emission). When the 
mitochondria were incubated with MDA at 37 °C, LFP production was already seen after 24 h 
of incubation, although it was very low. In 48 h sample there was a pronounced increase in 
LFP formation. In both samples the fluorescence maxi um, found from 3D spectra, was at 
365/440 nm (excitation/emission). When mitochondria were exposed to MDA at higher 
temperature, that is 50 °C, free radical reactions producing fluorescent LFP were even more 
accelerated. A slight production of LFP was observed in the sample of 4 h incubation. Well 
defined 3D fluorescence spectra were present in samples of 24 h and 48 h incubation. In the 
sample 24 h incubation we found the absolute fluorescence maximum at 355/430 nm 
(excitation/emission). From the 3D spectral array it was observed an increase of fluorescence 
in another area with the maximum at 290/390 nm. Similarly, 48 h incubation sample shows 
the maximum in that area at 310/420 nm. The absolute maximum in this sample was found at 
340/410 nm, which indicates a shift to lower excitation/emission wavelengths when compared 
with 25 °C and 37 °C (Fig. 13).  
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Synchronous excitation spectra confirm the rise of LFP production after 48 h of 
incubation, with the most obvious increase in the experiment carried out at 50 °C. 
Interestingly, the shape of synchronous spectra of 48 h samples obtained from incubation at 
37 °C and 50 °C did not differ remarkably from 0 h. Nevertheless, the 48 h sample from the 
experiment performed at 25 °C, although with lower LFP fluorescence when compared with 
higher temperatures, showed the difference in shape of synchronous spectra if compared with 
0 h (Fig. 14). 
The incubation of mitochondria with MDA at 25 °C, 37 °C and 50 °C showed that this 
reactive aldehyde reacted with mitochondrial components yielding fluorescent products at 
fastest rate at the highest temperature, where the LFP production was observed as early as 
four hours from the beginning of incubation. On theother hand, when the mitochondria were 
incubated with MDA at 25 °C the LFP production was not observed before 48 h. It is 
noteworthy that different temperature not only affects the amount of LFP produced, but also 














Fig. 13. Tridimensional fluorescence spectral arrays of extracts of beef heart mitochondria 
incubated with 100 µM MDA for 48 h. Panels A, B and C represent samples incubated at 25 









Fig. 14. Synchronous excitation spectra of extracts of beef h art mitochondria incubated with 
100 µM MDA. The panel A represents control sample (0 h) and the panels B, C and D 
represent samples incubated for 48 h at 25 °C, 37 °C and 50 °C, respectively. Fluorescence 










4.2.2 Qualitative HPLC analysis 
  
Chloroform extracts were analysed by HPLC with fluorescence detector in order to 
resolve particular fluorophores into distinctive fractions. The extracts were obtained from the 
experiment in which the kinetics of LFP production n mitochondria incubated with MDA at 
25 °C and 50 °C was followed. Fluorophore 350/440 nm (excitation/emission), found as 
maximum fluorescence in 3D spectra, was chosen for HPLC analysis. 
 From the chromatographic analysis of lipophilic extracts of mitochondria incubated 
with MDA at 25 °C (Fig. 15) it is apparent that specific fluorophore arose significantly only 
after 48 h of incubation. The fluorophore is represented by fraction 3 in the chromatogram. 
However, it is necessary to note that the peak can be observed even after 6 h from the 
beginning of incubation, although it is much smaller. It was not present at the onset of the 
experiment. The chromatographic analysis of lipophilic extracts of mitochondria incubated 
with MDA at 50 °C (Fig. 16) revealed that fluorophore assigned as F350/440 consisted of a 
few fractions. After 6 h of incubation there was a well-defined peak, lacking in previous 
samples, and which was present in the following samples. The analysis of 48 h sample 
revealed the production of two completely new fractions (2 and 4). 
 By increasing the temperature the LFP production was accelerated, as it is seen from 
the appearance of a new peak (fraction 3) 6 h from the start of incubation. In previous samples 
there is only a small rise of the baseline observed. Furthermore, 48 h incubation at 50 °C 
yielded two more fractions, confirming that fluorophores produced in the experiment are 







Fig. 15. The chromatograms obtained by HPLC analysis of lipophilic extracts of beef heart 
mitochondria incubated with 100 µM MDA at 25 °C. The ordinate indicates fluorescence 







Fig. 16. The chromatograms obtained by HPLC analysis of lipophilic extracts of beef heart 
mitochondria incubated with 100 µM MDA at 50 °C. The ordinate indicates fluorescence 





4.3 In vitro lipid peroxidation of mitochondria wit h tert-butylperoxide and 
peroxynitrite 
 
4.3.1 Incubation with 100 µM tert-BuOOH  
 
4.3.1.1 LFP fluorescence measurements 
  
 In this experiment the kinetics of in vitro lipid peroxidation of isolated beef heart 
mitochondria with tert-BuOOH and its dependence on c centration of the generator of free 
radicals were studied. The kinetics of lipid peroxidat on was assessed by analysing fluorescent 
end-products of the process. In the experiment with 100 µM tert-BuOOH, which was the 
lowest concentration of this lipid peroxidation init ator used in the experiments, incubation 
was carried out for up to 48 h.  
It was only in the 48 h sample that the LFP production occurred, according to the 
results obtained after the control 3D spectrum (0 h) had been subtracted from all the samples 
(Fig. 17). The fluorescence maximum found from 3D spectrum was 350/440 nm. The 
synchronous excitation spectra also revealed qualitative as well as quantitative changes 
occurred during in vitro peroxidation, with regard to fluorescence maxima found in these 
spectra. Comparing the control sample with 48 h sample, there is an evident increase in 
emission around 400 nm with the peak emission at 394 nm (Fig. 18). In the region of blue 
emission there is a shift in maximum emission wavelength to a lower value in peroxidized 
sample. The second derivatives of synchronous spectra give much finer resolution of emission 
maxima in a particular sample and nicely depict qualitative changes (Fig. 19). It shows that 
fluorescence pattern is different between non-peroxidized and peroxidized mitochondria. 
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According to spectrofluorometric measurements of lipophilic extracts of mitochondria 
incubated with 100 µM tert-BuOOH, it seems that only after long period of incubation with 
the generator of free radicals (48 h) end-products of lipid peroxidation are formed. In 
addition, basic fluorescence of non-peroxidized mitochondria differs from those exposed to in 





Fig. 17. Tridimensional fluorescence spectral array of extract of beef heart mitochondria 
incubated with 100 µM tert-BuOOH for 48 h. It is obtained after being subtracted from the 











Fig. 18. Synchronous excitation spectral arrays of extracts of beef heart mitochondria 
incubated with 100 µM tert-BuOOH at 25 °C. The panel A represents the sample obtained 
after 0 h of incubation, the panel B represents the sample obtained after 48 h of incubation. 





Fig. 19. Second derivatives of synchronous excitation spectral arrays of extracts of beef heart 
mitochondria incubated with 100 µM tert-BuOOH at 25 °C. The panel A represents the 
sample obtained after 0 h of incubation, the panel B represents the sample obtained after 48 h 
of incubation. Fluorescence intensity is expressed in relative fluorescence units. 
 
4.3.1.2 Qualitative HPLC analysis 
  
Chloroform extracts were analysed by isocratic HPLC with fluorescence detector set at 
350/440 nm (excitation/emission), after the fluorescence maximum had been found at these 
wavelengths (Fig. 20). The analysis was performed in order to resolve this fluorophore 
(F350/440) into fractions.  
63 
 
 Upon resolving the samples it was found that the relative abundance of one of the 
fractions (fraction 1), which elutes from the column around minute 9, changed during the time 
course of peroxidation. Its relative abundance becam  lower after 4 h and 6 h of incubation, 
when compared to time 0 h. At time 24 h it was slight y higher. This corresponds to the 
findings from fluorimetric measurements. In the sample obtained after 48 h of incubation, 
which showed the relevant increase in total LFP level visible from 3D spectra, the fraction 9 
was also increased. Another fraction (fraction 2) that elutes from the column after 15th minute 
did not change during the time course of incubation. 
 Isocratic HPLC analysis of F350/440 successfully resolved it into two significant 
fractions. The fraction 1 showed the changes in its amount, whereas fraction 2 remained 
constant during lipid peroxidation. Fraction 1, which had been already present in the control 









Fig. 20. The chromatograms obtained by HPLC analysis of lipophilic extracts of beef heart 
mitochondria incubated with 100 µM tert-BuOOH at 25 °C. The ordinate indicates 









4.3.2 Incubation with 200 µM and 1 mM tert-BuOOH 
  
4.3.2.1 LFP fluorescence measurements 
 
 The kinetics of in vitro lipid peroxidation, assessd by measurement of lipophilic 
fluorescent end-products, was further studied with h gher tert-BuOOH concentrations and the 
results were also compared with autooxidation of mitochondria. Lipid peroxidation was 
followed until 24 h from the beginning.  Tridimensional excitation spectra were measured in 
order to find fluorescence maxima at time 0h (Fig. 21) and 24 h (Fig. 22).  
 The fluorescence maximum was found at excitation/emission 357/440 nm. 
Furthermore, there were two additional fluorescence peaks at higher emission wavelengths: 
380/460 nm and 460/517 nm and these fluorophores were resolved by HPLC. 
As it was expected, the kinetics of production of fluorescent lipid peroxidation end-
products was affected by the concentration of tert-BuOOH. The higher concentration (1 mM) 
caused a rapider increase in LFP. What is also notewor hy is that mitochondria incubated in 
buffer without an oxidizing agent showed an increase in fluorescence at the end of incubation 
period (24 h). Thus, LFP formation is also partially due to autooxidation process. 
 
4.3.2.2 Qualitative HPLC analysis 
 
 Fluorophores found as fluorescence maxima in 3D spectra of lipophilic extracts were 
subjected to HPLC analysis with gradient elution in order to resolve them into fractions. 
Chloroform extracts were first analysed by gradient HPLC, in which mobile phase 
composition ranged from 10 % of organic solvent at the beginning of the analysis up to 75 % 
at the end (Fig. 23). The organic solvent used in the analysis was acetonitrile.  
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 The fluorophores were successfully resolved into several fractions. However, one 
fraction was of a particular interest. The retentio time of this fraction was around 16th 
minute. There were remarkable changes in size of this peak among different samples. For 
example, when compared to autooxidation samples of the same duration of incubation, in the 
samples with tert-BuOOH the peak is larger. This is particularly the case with 1 mM tert-
BuOOH. Additionally, it becomes larger as duration f incubation increases within one 
incubation group. Since one fluorophore is actually  mixture of various chemical species, 
which may be much alike in terms of their chemical structure, I tried to resolve this peak with 
a different mobile phase. The peak eluted when the solvent composition was between 40 % 
and 50 % of solvent B (pure acetonitrile) (Fig. 24). By using this mobile phase composition 
this fraction was resolved, as I expected, into a few more fractions. However, the largest peak 
eluted shortly after the start of analysis. Other peaks in the chromatograms were much smaller 
and they did not show a substantial change in size.
 The chromatographic methods used for the analysis of lipophilic extracts efficiently 
resolved the fluorophore mixture into a few fractions. Both methods, however, gave only one 
fraction which seemed to be interesting from lipid eroxidation point of view. 
 
4.3.3 Incubation with 2 mM and 4 mM ONOO-  
 
4.3.3.1 LFP fluorescence measurements 
 
The impact of different concentrations of ONOO- on production of lipid peroxidation 
fluorescent products and the kinetics of the production was studied in this experiment. Lipid 
peroxidation was followed until 24 h from the beginning. The results were compared with 
spectra obtained from mitochondrial autooxidation experiment. Tridimensional excitation 
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spectra were measured in order to find fluorescence maxima at time 0h (Fig. 21) and 24 h 
(Fig. 22). 
The fluorescence maximum was found at excitation/emission 355/430 nm. 
Furthermore, there were two additional fluorescence peaks: 358/500 nm and 360/450 nm and 
all these fluorophores were resolved by HPLC. In the samples with 2 mM ONOO- the 
fluorescence rose immediately (0 h) and yet it was much higher as the incubation proceeded. 
On the other hand, when the concentration of ONOO- was 4 mM, the LFP fluorescence was 
lower with the maximum at 358/500 nm (excitation/emission) at time 0 h. Moreover, 3D 
fluorescence spectral arrays showed the almost complete loss of fluorescence in the sample of 
mitochondria incubated for 24 h. 
The fluorescence measurement of lipophilic extracts revealed that the impact of 
ONOO- is concentration-dependent. While 2 mM concentration caused a significant 
fluorophores production, 4 mM ONOO- did not. It even caused a decrease in fluorescence 
during the time course of incubation. 
 
4.3.3.2 Qualitative HPLC analysis 
 
 Fluorophores found as fluorescence maxima in 3D spectra of lipophilic extracts were 
subjected to HPLC analysis with gradient elution in order to resolve them into fractions. The 
same methods used in the experiments with tert-BuOOH were applied in the experiments with 
ONOO-. 
 The most dramatic results were obtained when fluorophore F358/500 was resolved 
into fractions. Unlike other fluorophores, chromatographically analysed in this experiment, 
F358/500 from extracts with 2 mM ONOO- was resolved into two dominant fractions. The 
first fraction eluted between 14 and 15 minutes, whereas the second one appeared in the 
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chromatogram between 16 and 17 minutes (Fig. 25). With regard to the first fraction, the area 
under the peak and its height dramatically rose as the incubation proceeded. The same applies 
for the second fraction, although the relative increase during in vitro peroxidation is smaller. 
Similar findings were observed in chromatogram obtained when mobile phase consisting of 
40-50 % ACN was applied (Fig. 26). Interestingly, in the second fraction there is a small 
shoulder in front of the main peak, obviously indicat ng the presence of another fluorescent 
compound. This co-eluting peak, however, is no more apparent in the 24 h sample. When the 
same fluorophore was resolved in the samples with 4 mM ONOO- the fraction 1 was already 
sizeable at 0 h. Nevertheless, its size became slightly smaller as the incubation with ONOO- 
progressed. As for the fraction 2, it was much smaller than the fraction 1. The reverse 
situation was with 2 mM ONOO-. Furthermore, this fraction was tooth-shaped with two 
apparent peaks. It grew smaller as the incubation time went on and eventually it almost 
disappeared. When the other major fluorophores (F355/4 0 and F360/450) were resolved only 
one significant fraction was obtained. 
The chromatographic methods used for the analysis of lipophilic extracts efficiently 
resolved the fluorophore mixture into a few fractions. Chromatographic analysis confirmed 
the spectrofluorimetric results in which 2 mM ONOO- caused a remarkable increase of 









Fig. 21. Tridimensional fluorescence spectral arrays of mitochondrial lipohilic extracts. 
Mitochondria were incubated in 0.1 M phosphate buffer and spectral arrays show the time 0 h. 
A autooxidation; B incubation with 1 mM tert-BuOOH; C incubation with 2 mM ONOO-; D 







Fig. 22. Tridimensional fluorescence spectral arrays of mitochondrial lipohilic extracts. 
Mitochondria were incubated in 0.1 M phosphate buffer and spectral arrays show the time 24 
h. A autooxidation; B incubation with 1 mM tert-BuOOH; C incubation with 2 mM ONOO-; 








Fig. 23. The chromatograms obtained by HPLC analysis of lipphilic extracts of autooxidized 
mitochondria and the mitochondria incubated with 200 µM and 1 mM tert-BuOOH. The 







Fig. 24. The chromatograms obtained by HPLC analysis of lipphilic extracts of autooxidized 
mitochondria and the mitochondria incubated with 200 µM and 1 mM tert-BuOOH. The 







Fig. 25. The chromatograms obtained by HPLC analysis of lipphilic extracts of autooxidized 
mitochondria and the mitochondria incubated with 2 mM and 4 mM ONOO-. The ordinate 







Fig. 26. The chromatograms obtained by HPLC analysis of lipphilic extracts of autooxidized 
mitochondria and the mitochondria incubated with 2 mM and 4 mM ONOO-. The ordinate 





4.4 Oxidative stress during early postnatal development 
 
4.4.1 LFP fluorescence measurements 
 
 Lipophilic extracts from rat brains during perinatal and early postnatal development 
were analysed spectrofluorimetrically by means of tridimensional excitation spectra. The 
changes in LFP composition and production were studied in order to evaluate the kinetics of 
their production and the extent of free radical-mediated molecular damage in this period of 
animal development. LFP were used as markers of such reactions. 
 Tridimensional fluorescence spectral arrays, which are considered as a fingerprint for 
a particular mixture of fluorophores, revealed the changes in composition and relative 
abundance of certain fluorophores in the extracts from rat brains (Fig. 27). There were three 
major fluorophores, found as fluorescence maxima in 3D spectra: F325/380, F335/410 and 
F355/440. It was found that the relative amount of all the major fluorophores was the highest 
in postnatal day 2, after which there was observed a slight decrease. Furthermore, there was 
an obvious change in 3D spectra shape between postnatal day 90 and the samples from 
perinatal period. Interestingly, the maximum fluoresc nce at day 2 was at 335/410 nm, 
followed by 325/380 nm, while at day 90 it was at 355/440 nm.  
 Measurements of chloroform extracts from rat brain homogenates, in which LFP were 
analysed by means of spectrofluorimetry, disclosed that the production of various 
fluorophores is a dynamic process. LFP measurement can be a reliable tool for assessment of 








Fig. 27. Examples of 3D fluorescence excitation spectra of brain chloroform extracts. A 7 
days before birth, D postnatal day 2, J 3- month-old animals (taken from: Wilhelm J. et al.,









4.4.2 Qualitative HPLC analysis 
 
The fluorescent maxima obtained from 3D spectral arrays define the fluorophores with 
the largest relative concentration in a given sample. Thus as in my previous experiments these 
fluorophores, being a complex mixture of many different species, were resolved by isocratic 
HPLC with fluorescence detector adjusted at the wavelengths corresponding to the 
fluorescence maxima from 3D spectral arrays. Isocratic elution of e.g. F355/410 demonstrated 
the presence of many fractions, of which some were b tter separated, while other apparently 
co-eluted (Fig.28). The chromatograms also reveal, confirming the results of fluorimetric 
measurements, that the fractionation pattern is different throughout the development 
indicating changes in the composition of LFP. 
 
Fig. 28. Examples of the HPLC tracings of the fluorophore F355/410 in brain chloroform 
extracts of animals of different age: (A) 7 days befor  birth, (D) postnatal day 2, (E) 
postnatal day 5, (J) 3-month-old animals. The ordinate indicates fluorescence intensity at 
355/410 nm and the abscissa indicates time of analysis (taken from: Wilhelm J. et al., 2011). 
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4.5. Oxidative stress in erythrocytes from demented subjects 
 
4.5.1 LFP fluorescence measurements  
 
 Lipophilic extracts from erythrocytes of patients with cognitive dysfunction linked to 
“probable Alzheimer’s disease” and age-matched controls were analysed 
spectrofluorimetrically. Fluorophores were characterized by differential synchronous 
excitation spectra in order to find qualitative differences between two groups within the 
search for possible biomarkers of Alzheimer’s disease in blood.  
 The maximum difference in fluorescence between group f patients and control group 
was found at excitation/emission wavelengths 335/360 nm (Fig.29). Hence it must be 
regarded as quantitative difference, since there is a fluorescence maximum at these 
wavelengths in control group as well.   
 
Fig. 29. Synchronous fluorescence spectra of lipophilic extracts from erythrocytes. A 
represents a typical sample from dementia group; B represents a typical sample from control 
group. The ordinate indicates fluorescence intensity in arbitrary units (taken from: Ivica J. et 
al., 2011). Fluorescence intensity is expressed in relative fluorescence units. 
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4.5.2 Qualitative HPLC analysis 
 
 The fluorophore F335/360, which was found to differ in relative quantity the most 
between two groups, was analysed by isocratic HPLC method in order to resolve it into 
different fractions. The major fraction found in dem ntia group that eluted after 12th minute 




Fig. 30. Example of the chromatograms of fluorophore F335/360 in erythrocytes from: A 
control group, B dementia group. The ordinate indicate fluorescence i tensity in arbitrary 













Fluorescent LFP are established markers of oxidative stress of biological material and 
their increased production accompanies pathological processes. Lipophilic LFP, in particular, 
can be reliable and chemically stable indicators of lipid damage in cells. Since LFP are 
compounds having a fluorophore within their structure, they are most often characterized and 
analysed by means of spectrofluorimetry. In our experiments lipophilic LFP were measured 
using their intrinsic fluorescence properties. There are, however, papers describing the 
measurement of LFP by means of immunochemistry, with specific antibodies developed 
against certain LFP adducts (Itakura K. et al., 2000; Gu X. et al., 2003). 
We measured tridimensional fluorescence spectra along with differential 
(synchronous) spectra of extracts obtained from isolated mitochondria exposed to in vitro 
oxidation by various oxidizing agents. Mitochondria are regarded both as source and target of 
ROS (Anderson E.J. et al., 2012). Their membranes abound with lipids, notably 
phospholipids, whose peroxidation eventually leads to LFP formation. There are very few 
studies dealing with the analysis and the characterization of the lipophilic LFP formed in 
mitochondria as a result of oxidative stress. Mitochondrial LFP were studied either as a 
consequence of in vivo oxidation of biological material (Wilhelm J and Sonka J., 1981) or 
after being prepared artificially by in vitro oxidation (Nilsson E and Yin D. Z., 1997).  
Mitochondrial LFP were primarily analysed in order to acquire more information about these 
elusive heterogeneous compounds. In the paper by Wilhem and Sonka (1981) the time-course 
of LFP formation was monitored in rat liver homogenate and mitochondria after the whole 
body being radiated by gamma rays.   
In our work LFP were also artificially prepared by incubating heart mitochondria in 
vitro with various systems producing free radicals or products that induce chemical changes 
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leading to LFP formation. For example, mitochondria were incubated in vitro with lipid 
peroxidation product MDA, a well-known compound participating in fluorescent LFP 
formation. There are more studies that investigated the formation of fluorescent pigments 
after MDA was incubated in vitro with, for example, cell membranes (erythrocyte) or vesicles 
containing different phospholipids. Those studies were undertaken in order to examine the 
metabolome of various fluorescent pigments generated from MDA. When erythrocytes were 
incubated with MDA with concentrations similar to the one used in our experiment, 
maximum fluorescence was found at 360/440 nm (excitation/emission) (Goldstein B. D and 
McDonagh E. M., 1976). When MDA (1 mM) was incubated for 24 h at 37 °C with 
artificially made vesicles composed of L-α-phosphatidylethanolamine 1-palmitoyl-2-oleoyl 
and L-α-phosphatidylethanolamine dioleoyl, LFP fluorophores with maximum fluorescence at 
400/470 nm were generated (Wang J. Y. et al., 1996). MDA has been also used in several in 
vitro studies where it was incubated with some amino-group containing compounds. MDA 
was incubated with particular compounds in order to elucidate the chemical structure of LFP 
produced as well as to investigate the spectral properties of the fluorescent end-products. 
MDA was thus reacted, for example, with an artificially prepared phospholipid containing 
ethanolamine (Trombly R and Tappel A., 1975). Furthermore, MDA was incubated with very 
simple compounds such as taurine, GABA, glucosamine or pyridoxamine and the products of 
all of those reactions were, among others, fluorescent LFP (Kang Z. et al., 2006; Fang C. et 
al., 2007; Deng Y. et al., 2011 Deng Y. et al., 2012).  The concentration of MDA used in the 
experiments with pyridoxamine and glucosamine was in m llimolar range - 5 mM, or even 
higher - 20 mM when the reactive aldehyde was incubated with lysine-derivative or 
propylamine (Slatter D.A. et al., 1998; Kang Z. et al., 2006; Fang C. et al., 2007). As for 
MDA concentration chosen in our experiment, it was micromolar (100 µM) and closer to the 
levels that can be found in vivo, but still rather igh so that it would exert its toxic effect on 
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biological compounds. pH of the incubation mixture was deliberately set as acidic because 
MDA at lower pH is mostly present in its keto form and not enolate form. Enolate form is 
dominant at neutral pH. Keto form of MDA, having two aldehydic groups, is highly reactive 
and it easily attacks amino-groups of biological comp unds (Halliwell B and Gutteridge J. M. 
C., 2007). In our experiments the focus was actually on studying the kinetics of LFP 
production in mitochondria incubated with MDA and how this kinetics is affected by 
incubation temperature. As expected, the higher the temperature the faster LFP production it 
was. LFP were analysed spectrofluorimetrically and by means of HPLC. The results of 
spectrofluorimetric measurements, in the form of spectral arrays, confirm that the incubation 
of mitochondria with MDA leads to fluorescent LFP generation. The emission maxima were 
in the blue region, which is typical for LFP. In tissues, such blue-emitting pigments arise 
mainly as a result of ROS overproduction and their rise accompanies pathologies linked to 
oxidative stress. Specifically, the emission maxima found in our experiment were from 410 – 
440 nm, depending on the time of incubation and temperature. As for the excitation maxima, 
they were in the range 340-365 nm, again depending o  the time of incubation and 
temperature. If LFP formation is accelerated, in our case by increased temperature, there was 
a tendency of production of fluorophores that emit at around 400 nm when excited at around 
300 nm. The similar fluorescence pattern with two maxi a was observed in tridimensional 
spectral arrays of lipophilic extracts of erythrocytes withdrawn from rats exposed for 4 days 
to hypoxia (Skoumalova A. et al., 2008). Although it is obvious from tridimensional spectra 
that the incubation of mitochondria with MDA produces a completely new metabolome of 
fluorescent compounds, we attempted to further analyse individual fluorophores by HPLC. It 
has been known that particular fluorophores consist of a number of different compounds that 
can be resolved by using various chromatographic techniques. In our work a new method for 
qualitative analysis of LFP from mitochondria was developed. Wilhelm and Herget (1999) 
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described and developed method for isocratic chromat gr phic analysis of LFP arisen during 
hypoxia and hypoxia-reoxygenation in rat spleen anderythrocytes. We established also an 
isocratic method that was used for resolution of fluorophores generated in mitochondria after 
being incubated with MDA. We succeeded to resolve produced fluorophores into several 
distinct fractions. From chromatographic data we can see that certain fluorophores consist of 
several fractions. Individual fractions obtained in our analyses can, however, represent more 
than one chemical species. Thus fluorescent LFP are ind ed a complex mixture of many 
different compounds. LFP are formed, for example, as a consequence of lipid peroxidation 
and reactive aldehydes are the main culprit for their production. However, the cascade of the 
reactions yielding LFP is slow. In attempt for generation a bigger quantity of LFP in vitro and 
to accelerate the process, we chose to incubate mitochondria MDA at high temperatures. 
From chromatographic results we see that the incubation of heart mitochondria with MDA 
after some time gives new peaks belonging to one or more unknown fluorescent compounds 
or adducts. This can be due to direct reaction of the added reagent with mitochondrial 
component or perhaps its polymerization, but also there is a possibility of newly synthesized 
reactive species during incubation process that leads to LFP formation.   
Apart from the in vitro incubation of heart mitochondria with lipid peroxidation 
product MDA, the organelles were exposed to direct in vitro lipid peroxidation by ferrous ions 
and ascorbic acid or tert-BuOOH. Again we studied in etail the kinetics of LFP production. 
These two systems have been known as good generators of f ee radicals involved in lipid 
peroxidation (Melin A. M. et al., 1997; Micciche F.et al., 2005; Baron C. P. et al., 2006; 
Petrosillo G. et al., 2009). Furthermore, the mitochondria were exposed to oxidizing and 
nitrating agent peroxynitrite, which had been used in experiments as prooxidative agent 
initiating lipid peroxidation before (Kolodziejczyk J. et al., 2011; Singh I. N. et al., 2007). 
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Lipid peroxidation was assessed by fluorescence measur ments of LFP produced during 
incubation. 
 Tridimensional as well as synchronous spectra reveal that the fluorescent LFP 
generated in mitochondria incubated with iron-ascorbate system undergo chemical 
modifications in the course of incubation. This is deduced if we take a look at the changes of 
the shape of, in particular, tridimensional spectra of respective samples. In both experiments 
with iron and ascorbate there were two hilly regions i dicating production of LFP with 
different fluorescence properties, with neither being a dominant one. If we compare the results 
from two separate papers describing in vitro lipid eroxidation of erythrocyte membranes 
with iron-ascorbate, we find the same fluorescence maximum of LFP produced, which 
somewhat differ from our fluorescence maxima found i  mitochondrial extracts. Precisely, 
one was 350/430 nm (Wilhelm J. et al., 2005) and the other 355/430 nm (Skoumalova A. et 
al., 2008).  
When heart mitochondria were exposed to in vitro lipid peroxidation initiated by tert-
BuOOH the rate of LFP production was dependent on tert-BuOOH concentration. However, 
the fluorescence maxima were almost the same in allcases, with the only slight difference in 
maximum excitation wavelength (350 nm with 100 µM tert-BuOOH and 357 nm with 1 mM 
tert-BuOOH). The emission was the highest at 440 nm. The spectra obtained after lipid 
peroxidation with tert-BuOOH show the high similarity with those seen in the experiment 
with MDA at 37 °C. When erythrocyte membranes were exposed to tert-BuOOH, although in 
much higher concentration (10 mM), the fluorescence maximum was found to be at 350/420 
nm (excitation/emission) (Skoumalova A. et al., 2012). 
In the experiments with peroxynitrite LFP were produced immediately upon adding 
the agent, although when lower concentration was used (2 mM). This implies that 
peroxynitrite reacts much faster than other oxidants used in our experiments and that it causes 
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chemical rearrangements that yield LFP very quickly. However, the maximal fluorescence in 
the samples with 2 mM ONOO- was similar to the one found in the experiments with tert-
BuOOH. The maximum excitation was at 355 nm and the emission at 430 nm. When the 
concentration of peroxynitrite added to mitochondria was double, tridimensional spectra 
revealed there was completely different composition of fluorophores present in the extracts. 
The emission maximum was in another region and it was 500 nm after excitation at 358 nm. 
If we compare the spectral arrays of lipophilic extrac s with both concentrations upon adding 
peroxynitrite, we can see that sharp increase in fluorescence in the blue region observed with 
2 mM ONOO- is thoroughly missing in the sample where 4 mM ONOO- had been added into. 
Furthermore, even after 24 h incubation the fluorescence pattern remained unchanged and 
there was a decrease in fluorescence in aforementioned region around 500 nm, which saw the 
emission maximum of the whole spectrum.  
As seen in the experiments with MDA, the fluorophores found in spectral arrays with 
maximum fluorescence, obtained after in vitro lipid peroxidation with tert-BuOOH and 
peroxynitrite, were analysed by HPLC. Generally, the publications describing the analysis of 
LFP from biological material using chromatographic te hniques are very scarce. Therefore, it 
was necessary to develop chromatographic method in our laboratory, which will enable 
separation of various fractions. This is especially essential for LFP from diverse biological 
samples, where the pigments are usually present in complex mixtures. We first developed 
method using reverse phase system with isocratic elution and afterwards the methods using 
gradient system were introduced. Fluorescence detector was used exclusively, for we intended 
to analyse only fluorescent products of lipid peroxidation. With regard to the analysis of 
various LFP by HPLC, some pigments prepared by reaction of amine-group containing 
compounds with the products of lipid peroxidation were reported to have been characterized 
by this separation method using different detecting ools. Adducts prepared from MDA and 
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cysteine residues were measured by liquid chromatogr phy-mass spectrometry system 
(Chowdhury P. K. et al., 2004). Itakura et al. (2000) used isocratic reversed-phase HPLC with 
fluorescence detector in order to analyse fluorophore derived from lysine-derivative and 4-
oxo-2-nonenal. Similarly, the authors from the same laboratory analysed lysine-derived 
fluorophore generated from oxidized linoleic acid using fluorescence detection (Itakura K and 
Uchida K., 2003). Furthermore, lipid peroxidation ed-products formed in the reaction 
between MDA and propylamine were analysed by HPLC with photodiode detector, after 
reactants had been incubated in phosphate buffer for 6 h and 7 days. The incubation over long 
period (7 days) yielded, as apparent on chromatogram, multiple peaks. (Kang Z. et al., 2006). 
This is consistent with our findings that lipid peroxidation end-products generated from MDA 
are diverse compounds, with more products formed as time of incubation increases. However, 
it must be noted that not all of the end-products are fluorophore-bearing compounds. 
Chromatographic analysis of fluorescent LFP formed in mitochondria peroxidized by 
tert-BuOOH in concentrations up to 1 mM basically gave one fraction, which saw a 
substantial change during the course of an experiment. This was the case with isocratic and 
gradient method alike. In our case, the fluorescent species are of unknown structure, i.e. 
unidentified and therefore chromatographic separation using gradient elution suits better for 
such samples. By starting with mobile phase composition that has high percentage of water, 
which cannot remove the fraction of interest from column, and with a subsequent gradual rise 
of acetonitrile content, we were able to finely resolve the fraction from the interfering peaks. 
LFP formed during incubation of mitochondria with ON O- were analysed by HPLC 
using the same methods with gradient as with tert-BuOOH. However, the results were more 
spectacular, as it was also seen from spectrofluorometric measurements. Thus, in the 
chromatograms can be seen two dominant fractions, with both increasing in peak area and 
height as incubation time goes on. The first fraction undoubtedly arose in response to the 
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exposure of mitochondria to ONOO-, as it was not present in non-peroxidized or autooxidized 
mitochondria. The second fraction has the same retention time as the one from autooxidation 
experiments as well as the fraction appearing in the experiments with tert-BuOOH. It was the 
second fraction that actually disappeared after 24 h incubation of mitochondria with 4 mM 
ONOO-. On the other hand, the peak regarded as the first fraction was almost 20 times higher 
with 4 mM ONOO- at the beginning of the experiment than with 2 mM ONOO-. Nevertheless, 
after 24 h incubation this peak grew smaller in the sample where 4 mM ONOO- was added. 
These analyses, together with afore described spectral measurements, indicate that high 
concentrations of peroxynitrite destroy LFP species accumulated at lower peroxynitrite 
concentrations. This is a unique behaviour that wasnever observed with other free radical 
generating systems. 
Oxidative stress and the damage to biological material are well documented as 
relevant contributors to pathophysiology of many diseases. Hence the indicators of oxidative 
damage are usually measured in such subjects to estimate, for example, the extent of damage. 
Particular compounds can be found in low levels even in normal or disease-free subjects, 
which is due to continuous ROS production in mitochondria or other sites. In oxidative stress 
a huge increase in their level is usually observed. Furthermore, during certain pathological 
process, which is connected to ROS overproduction, c mpletely new products may be formed 
as consequence.  
Indicators of oxidative stress are found early in the pathogenesis of AD (Gustaw-
Rothenberg K. et al., 2010). We propose that LFP could be useful biomarkers of this 
pathological condition. LFP formed in erythrocytes, which can diffuse through circulation 
into the site of high ROS production in brain, were analysed. The measurement of erythrocyte 
LFP is very convenient for the cells can be easily i olated after blood has been withdrawn. 
Spectrofluorimetric measurements revealed the increased level of fluorophore 350/440 nm 
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(excitation/emission) in subjects with dementia of AD type when compared with age-matched 
controls. When the fluorophores that showed the biggest difference between the two groups 
were analysed by HPLC, the most significant results were observed with the fluorophore 
F335/360. HPLC analysis of this fluorophore showed one remarkable fraction that was 
present in AD samples and it was barely present in the control samples. This might represent 
some new fluorescent compound, which is strictly a product of ROS attack involved in 
pathogenesis of AD. This metabolite might be specific for the processes occurring in AD. 
Development of separation method is thus a prerequisite for further, a more detailed 
characterization of such metabolites. 
If we compare the results of the qualitative HPLC analysis of fluorescent pigments 
from the heart mitochondria and erythrocytes, we can observe that in both cases there was just 
one significant peak that differed between oxidatively altered samples and the control 
samples.  
The increased ROS production is not only linked to pathologies, but also with certain 
conditions such as normal ageing or during birth. It is to be expected that there is an increased 
production of ROS after birth due to a sharp rise in oxygen concentration. We measured LFP 
directly from brain of rats in perinatal period and during early development of the animals. In 
another study, it was found that during the first few hours after birth DNA from rat liver and 
kidney was damaged by ROS. The damage was similar to the level of injury found in 24-
month-old rats (Randerath E. et al., 1997). Our results indicate a transient accumulation of 
LFP in neonatal brain. Maximum content of several fluorophores was found on the postnatal 
day 2, after which the levels were falling down and on the day 10 dropped to prenatal levels. 
LFP concentration rose significantly again in 3-month-old animals. Rat brain homogenates 
had three major fluorophores, out of which F335/410 exhibited maximum fluorescence. 
HPLC analysis of this fluorophore revealed that it can be resolved into several 
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chromatographically distinct compounds. Again, each fraction seen as a peak might represent 
more than one chemical species. 
For comparison, HPLC analysis of the rat brain homogenates gave much more peaks 
in the chromatograms than when mitochondria or erythrocytes were used as sample material. 
This is not surprising since the entire brain tissue was extracted, which gives more sources of 
LFP than isolated cells or organelles. 
Analysis of LFP from rat brain during early postnatal development and from human 
erythrocytes of patients with dementia of AD type indicates the presence of an entire 
metabolome of compounds arising as products of freeradical reactions. Their chemical 




















 In this work, we developed several chromatographic methods for the separation of 
fluorescent LFP formed as products of free radical re ctions in different biological systems.  
We applied these methods for the analyses of fluorescent products generated in beef heart 
mitochondria exposed in vitro to various free radicl generators, in erythrocytes membranes, 
and in developing rat brain. 
 On analysing LFP from various sources by means of flu rescence spectroscopy and 
HPLC, we found a whole metabolome of different fluorescent compounds. These compounds 




















 Lipofuscin-like pigments are products of reactions i volving free radical attack onto 
molecules with nucleophilic groups. They can be formed, for example, in the reactions 
between lipid peroxidation decomposition products, such as aldehydes, and amino-group 
containing compounds, e.g. phospholipids, peptides. Owing to their intrinsic fluorescent 
properties LFP can be easily measured. LFP are relatively stable and therefore have been 
successfully used as robust markers of oxidative damage. 
 We undertook the metabolomic studies, where fluorescent LFP were first analysed 
spectrofluorimetrically by using tridimensional and differential fluorescence spectral arrays. 
After that, certain LFP were analysed by means of high performance liquid chromatography, 
in order to resolve the mixture of compounds into distinct fractions. For this purpose we used 
LFP prepared after isolated heart mitochondria had been exposed in vitro to oxidative stress 
initiated by various triggers. LFP were also analysed during early development in rat brain, 
which is accompanied by transient increase in oxygen concentration, and in erythrocytes from 
patients with Alzheimer’s disease. 
 We developed HPLC methods for qualitative analysis of LFP of different origin. This 
analysis unfolded that LFP indeed consist of many chromatographically different species. By 
this way we confirmed the existence of a great number of individual fluorescent species 










 Lipofuscinoidní pigmenty (LFP) jsou produkty reakcí, ve kterých volné radikály 
napadají molekuly s nukleofilními skupinami. LFP vznikají např. v reakcích mezi produkty 
rozkládaní peroxidů lipidů, což jsou hlavně reaktivní aldehydy, a sloučeninami obsahujícími 
aminoskupiny (fosfolipidy, peptidy). LFP lze snadno měřit díky jejich vnitřní fluorescenci. 
Tyto produkty jsou poměrně stabilní, a proto byly úspěšně využívány jako robustní markery 
oxidačního poškození. 
 Provedli jsme metabolomické studie, přičemž LFP byly nejprve analyzovány 
fluorimetricky pomocí trojrozměrných a diferenciálních fluorescenčních spekter. Potom jsme 
LFP analyzovali pomocí vysokoúčinné kapalinové chromatografie s cílem rozdělit směs látek 
na jednotlivé frakce. LFP jsme získali z izolovaných mitochondrií vystavených in vitro 
oxidačnímu stresu zahájenému různými spouštěči. LFP byly rovněž analyzovány v potkaních 
mozcích během časného rozvoje, což je doprovázeno přechodným zvýšením koncentrace 
kyslíku, a v erytrocytech z pacientů s Alzheimerovou chorobou. 
 Vyvinuli jsme HPLC metodu pro kvalitativní analýzu LFP odlišného původu. Tato 
analýza objevila, že se LFP opravdu skládají z mnoha c romatograficky odlišných látek. 
Tímto způsobem jsme potvrdili jsoucnost velkého počtu jednotlivých fluorescenčních látek, 
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